Bone loss during critical illness: A skeleton in the closet for the intensive care unit survivor?* "I have no history but the length of my bones."-Robin Skelton A s more patients receive multiple organ support in critical care units, many of whom are elderly and/or have significant comorbidities, attention is turning toward an ever increasing population of intensive care unit (ICU) survivors (1) . Critical illness is recognized to result in a "post-ICU syndrome," which can occur whatever the original presenting illness and result in cognitive, neurologic, and physical function impairments, which significantly affect patients' quality of life for many months or years (2) . These impairments and disabilities also place a heavy burden on healthcare systems and caregivers (3) . In recent years, our knowledge of the prevalence of psychologic and physical problems has improved through cohort studies, and research is beginning to explore the risk factors, mechanisms, and possible treatments that may affect the severity and duration of issues ranging from psychologic conditions such as posttraumatic stress disorder to physical problems such as fatigue and breathlessness. Until now, very little work has specifically investigated the affect of critical illness on the skeleton, having focused mainly on neuromuscular dysfunction.
Osteoporosis is a major public health issue that has been estimated to affect 55% of Americans aged Ն50 yrs, of whom 80% are women (4). It is responsible for millions of fractures annually, mostly involving the lumbar vertebrae, hip, and wrist. The World Health Organization defines osteoporosis as a bone mineral density that is Ͼ2.5 SDs below the mean bone mineral density of young adult women (5) . The disease can be classified as primary type 1, primary type 2, or secondary. Primary type 1 or postmenopausal osteoporosis is the form most common in women after menopause, whereas primary type 2 osteoporosis occurs after age 75 yrs and is seen in both females and males at a ratio of 2:1. Secondary osteoporosis may arise at any age and affects men and women equally. This form of osteoporosis results from chronic predisposing medical problems or disease or prolonged use of medications such as glucocorticoids.
A significant proportion of patients admitted to ICUs will possess strong risk factors for osteoporosis such as female gender, older age, a positive family history, low body mass index, and white origin. Many will also be smokers, have a history of prior corticosteroid use, chronic inflammatory disease, or reduced mobility (6). Although no studies have formally quantified the prevalence of osteoporosis among patients admitted to critical care units, it is likely that many have this condition. Given the potential for osteoporosis-related fractures to impact on long-term quality of life, together with the availability of potential treatments, it is relevant to understand whether an episode of critical illness increases its severity or rates of disease progression and complications.
In this issue of Critical Care Medicine, Orford and colleagues (7) address this issue. They are the first to examine fracture incidence in patients who survive critical illness. The authors estimated fracture incidence for both men and women cared for in a major Australian ICU who required Ͼ48 hrs of mechanical ventilation and were able to compare the female cohort with age-matched control subjects from a high-quality prospective population-based osteoporosis study from the same region. Fracture incidence was assessed in the cohort of patients discharged after critical illness by searching electronic radiology reports for a median follow-up time of 3.7 yrs for females and 4 yrs for men. They found that 14% of female and 10% of male survivors who had been ventilated for Ͼ48 hrs sustained fractures in the follow-up period. In female survivors, the overall incidence trended to a higher fracture rate over the follow-up period than was present in the population control subjects, but this was not statistically significant (hazard ratio, 1.20; 95% confidence interval, 0.84 -1.71; p ϭ .31). Interestingly, when older female patients (aged Ն60 yrs) were analyzed as an age-matched subgroup, there was a statistically significant increase in fracture rate suggesting clinically important increases in fracture rates (hazard ratio, 1.65; 95% confidence interval, 1.08 -2.52; p ϭ .02). Because older women are more likely to have coexisting osteoporosis when they have their critical illness and/or are more prone to developing it, this observation raises the possibility that critical illness itself may accelerate osteoporosis development and increase the chance of fracture.
The study was not prospective such that fracture detection relied on patients having undergone imaging in the radiology departments included in the region. It is possible that fracture underdetection occurred in both critically ill and control populations, and ascertainment bias resulting from imbalance between the groups cannot be excluded. The excess of fractures in the female ICU survivors was attributable largely to vertebral fractures. These comprised a much higher proportion of the fractures in the ICU cohort (41.7%) than the population control cohort (17.4%) and could also be a form of ascertainment bias perhaps attributable to increased imaging in post-ICU patients, for example, chest radiography for respiratory symptoms. As pointed out by the authors, the retrospective design also makes it difficult to disentangle preexisting risk factors from the effects of critical care, and confounding factors may not have been adequately controlled for. Despite these limitations, the findings raise the possibility that critical illness increases the risk of subsequent osteoporotic fractures.
Bone turnover can be assessed in patients using various biochemical markers (8). These have been broadly categorized as collagenous bone resorption markers, osteoclast regulatory proteins, and bone formation markers. Peptide fragments from the breakdown of mature collagen are the most commonly used measures of bone resorption and include the pyridinolines (pyridoniline and deoxypyridinoline), which can be detected in the serum and the urine (8). Increased bone turnover in critically ill patients, particularly those who require multiple organ support for prolonged periods, has been reported in the literature for well over a decade (9 -11). Shapses and colleagues (9) compared bone turnover in a small sample of critically ill patients after gastrointestinal surgery, all of whom were receiving parenteral nutrition, with agematched healthy volunteers. Excretion of pyridinium crosslinks was increased in the critically ill sample when compared with healthy volunteers and was more pronounced in patients who had a longer ICU stay. Smith et al (10) reported increased bone resorption compared with healthy control subjects in 23 patients with sepsis and trauma measured using pyridinoline/creatinine and deoxypyridinoline/creatinine ratios. The authors found this was particularly pronounced in the subgroup of septic patients who had a tenfold increase in pyridinoline/ creatinine ratio and a sixfold increase in deoxypyridinoline/creatinine ratio. Serum markers of osteoblast activity were increased at ICU admission in Van Den Berghe's study of vitamin D in critically ill patients compared with healthy control subjects. This was accompanied by a similar increase in urinary deoxypyridinoline and pyridinoline implying upregulation of both osteoclast and osteoblast activity but with an imbalance in favor of bone resorption (11). These studies all suggest that critical illness is associated with changes to normal bone metabolism, which most likely favor bone breakdown and demineralization.
Although the impact of critical illness on bone mineralization is ill defined, much can be inferred from other settings and the known pathophysiological processes that occur. Factors known to cause bone loss are summarized in Table 1 and have been recently reviewed by Via and colleagues (12). The multiple potential mechanisms whereby critical illness could result in excessive osteoclast activity, bone loss, and demineralization provide a strong biologic plausibility for increased risk of subsequent osteoporosis, especially after prolonged critical illness.
Although the study by Orford and colleagues requires validation in prospective, adequately controlled studies with a low risk of bias, their findings are particularly interesting because potential therapies exist to prevent or minimize the detrimental effects of critical illness on bone metabolism. These include vitamin D and biphosphonate therapy. Biphosphonates in particular are well-established effective treatments for osteoporosis, bone metastases, and other bone diseases. They act by promoting osteoclast apoptosis, thereby reducing bone loss. Some small studies have used both vitamin D and biphosphonates in critically ill patients and demonstrated biochemical evidence of reduced bone resorption (11, 16). The overall excellent safety profile of biphosphonates make them a potentially attractive therapeutic option for the chronically critically ill, although caution is required in patients with renal failure and they have also been associated with fever and atrial fibrillation, both of which could have adverse effects in frail patients.
Orford et al have opened a new avenue of research into the consequences of critical illness. Their data support the need for well-designed prospective cohort studies to confirm whether critical illness increases the risk of subsequent osteoporosis-related fractures together with further well-designed studies to determine the factors that increase bone loss during intensive care. Clinical trials of biphosphonates and/or vitamin D to determine the risk-to-benefit profile of these agents in patients with organ dysfunction are needed. However, the ready availability of these agents raises true hope that intervening in the right patients at the right time during critical illness might result in long-lasting benefits to patients' subsequent quality of life.
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Clinical Meaning of a Positive Quantitative Catheter Culture
In the monocentric study from Mrozec et al (6), systematic positive catheter culture in the absence of positive blood culture was associated with only 1.3% of subsequent bloodstream infection. This rate of subsequent bloodstream infection was not impacted by antimicrobial treatment. The authors concluded that isolated positive quantitative catheter culture could be considered as a simple colonization without any evidence of catheter-related infections.
The major inclusion criteria differentiating the study of Mrozec et al (6) from the others is that catheter culture was performed systematically, although the ICU has a low rate of catheter colonization. The present study is the only one having used quantitative culture. The specificity of the technique is comparable to the one semiquantitatively (3) and cannot explain this result. Furthermore, it is consistent with the estimated positive predictive value of the technique of 7% when the prevalence of catheter-related bloodstream infection is Ͻ1% (3).
In the Infectious Diseases Society of America guidelines (7), it is clearly mentioned that catheter culture should be performed when a catheter is removed for suspected CRBSI and that catheter culture should not be routinely performed.
However, this recommendation could not be applied in the ICU, because a systemic inflammatory response syndrome is present in Ͼ80% of the patient-days (8). Furthermore, we found in a prospective randomized study involving 3,276 catheters in ICUs (9, 10) that abnormal temperature was present in 1,674 (51%) cases at the time of catheter removal. Furthermore, two of the four systemic inflammatory response syndrome criteria were present in 2,854 (87%) cases. Safdar and coworkers (11) have shown that local signs are not predictive of catheter infections in the ICU.
Finally, the rate of catheter removal without local signs of infections and without systemic inflammatory response syndrome criteria (392 [11%]) became so infrequent in the ICU that a systematic culture is in fact required.
In the present study, the presence or the absence of systemic or local signs of infections has not been systematically collected. However, it should be pointed out that one subsequent bacteremia of two occurred on a patient whose central venous catheter was removed because it was no longer needed, underlying the subjectivity of the infection suspicion criteria. Furthermore, in a previous study exploring the significance of isolated positive culture (12-14), the presence of systemic inflammatory response syndrome criteria or local signs was not predictive of subsequent infections.
Accepting the fact that it is uneasy, in the sickest patients, to define the suspicion of catheter-related infection, the absence of antimicrobial treatment should be questioned. Recent studies that have
